Harry D. Bear
Impact in
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 116
- Cancer Immunotherapy and Biomarkers 30
- CAR-T cell therapy research 29
- Cancer Treatment and Pharmacology 21
- HER2/EGFR in Cancer Research 16
- Immunology 69
- Immunotherapy and Immune Responses 51
- Immune Cell Function and Interaction 31
- Co-authors
- Norman Wolmark (17 shared papers)Eleftherios P. Mamounas (16 shared papers)Richard G. Margolese (12 shared papers)D. Lawrence Wickerham (8 shared papers)Bernard Fisher (6 shared papers)Stewart Anderson (5 shared papers)Charles E. Geyer (12 shared papers)Masoud H. Manjili (25 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Breast Cancer Research and Treatment (11 papers)Cancer Research (9 papers)Cancer Immunology Immunotherapy (8 papers)The Journal of Immunology (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Harry D. Bear
170 papers receiving 11.2k citations
Harry D. Bear's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 6.4k
- Oncology 6.6k
- Pathology and Forensic Medicine 3.5k
- Immunology 1.9k
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Harry D. Bear
This map shows the geographic impact of Harry D. Bear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry D. Bear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry D. Bear more than expected).
Fields of papers citing papers by Harry D. Bear
This network shows the impact of papers produced by Harry D. Bear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry D. Bear. The network helps show where Harry D. Bear may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry D. Bear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Hit paper breakdown → | 1998 | 1688 |
| 2 | Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Hit paper breakdown → | 2008 | 1319 |
| 3 | The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Hit paper breakdown → | 2003 | 865 |
| 4 | Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Hit paper breakdown → | 2006 | 722 |
| 5 | Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 Hit paper breakdown → | 2012 | 394 |
| 6 | 2005 | 384 | |
| 7 | 1999 | 377 | |
| 8 | 1999 | 344 | |
| 9 | 2012 | 320 | |
| 10 | 2007 | 299 | |
| 11 | 2009 | 290 | |
| 12 | 2013 | 261 | |
| 13 | 2020 | 229 | |
| 14 | 2009 | 175 | |
| 15 | 2008 | 155 | |
| 16 | 2019 | 140 | |
| 17 | 2003 | 134 | |
| 18 | 2009 | 126 | |
| 19 | 2011 | 124 | |
| 20 | Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1. | 1992 | 110 |
About Harry D. Bear
Harry D. Bear is a scholar working on Oncology, Immunology, Cancer Research, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 173 papers that have together received 11.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (51 papers), Breast Cancer Treatment Studies (49 papers), Immune Cell Function and Interaction (31 papers), Cancer Immunotherapy and Biomarkers (30 papers), CAR-T cell therapy research (29 papers), Breast Lesions and Carcinomas (27 papers), Cancer Treatment and Pharmacology (21 papers) and HER2/EGFR in Cancer Research (16 papers). The work is most often cited by research in Cancer Research (6.4k citations), Oncology (6.6k citations), Pathology and Forensic Medicine (3.5k citations), Immunology (1.9k citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Harry D. Bear has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Norman Wolmark, Eleftherios P. Mamounas, Richard G. Margolese, D. Lawrence Wickerham, Bernard Fisher, Stewart Anderson, Charles E. Geyer, Masoud H. Manjili, André Robidoux and James L. Hoehn. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Cancer Immunology Immunotherapy and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.